Anti-cancer compounds targeting Ral GTPases and methods of using the same
USRE48557E1 · kind E1 · reissue
0Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2019 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Aug 27, 2039 |
Classification
- Technology area (CPC —)General
Abstract
Methods of inhibiting the growth or metastasis of a cancer in a subject by inhibiting a Ral GTPase in the subject, and small molecule inhibitors of Ral GTPases useful in the methods of the invention. Pharmaceutical compositions containing the compounds of the invention, and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.